Stocks and Investing Stocks and Investing
Mon, January 27, 2025
[ Last Monday ] - MSN
Karyopharm Therapeutics' SWOT analysis: biotech stock faces pivotal year
[ Last Monday ] - MSN
Diworsification: When too much diversification hurts your investments
[ Last Monday ] - MoneyWeek
DeepSeek: Chinese chatbot sends shockwaves through US stock market
[ Last Monday ] - MSN
STAG Industrial's SWOT analysis: diverse portfolio shields stock amid market shifts
[ Last Monday ] - MSN
3 Blue-Chip Retail Stocks You Can Trust for Long-Term Gains
[ Last Monday ] - Kiplinger
Stock Market Today: Markets Tumble on DeepSeek Shock
[ Last Monday ] - WOPRAI
Short squeeze is starting in shares of KVUE at $2 .. 9, after crossing above the $21.473 Trigger Price
[ Last Monday ] - Forbes
Super Micro Computer Stock: Where Is It Heading In 2025?
[ Last Monday ] - MSN
The one Australian stock to buy and hold forever in an ASX share portfolio
[ Last Monday ] - WOPRAI
Short squeeze is starting in shares of ESCA at $1 .. 5, after crossing above the $15.896 Trigger Price
[ Last Monday ] - Investopedia
The Surprising Role Alternative Investments Play in Portfolio Diversification
[ Last Monday ] - MSN
Billionaires Selling AI Stocks to Buy This ETF that Has 42% Upside According to Wall Street Guru
[ Last Monday ] - WOPRAI
Brian Brophy Maintained (ECG) at Buy with Increased Target to $85 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Joshua Chan Maintained (KLC) at Buy with Decreased Target to $28 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Stephen Gengaro Maintained (SEI) at Buy with Increased Target to $42 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Justin Jenkins Initiated (CCEC) at Outperform and Held Target at $26 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Daniel Ives Maintained (OKLO) at Outperform with Increased Target to $45 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Jones Maintained (VLTO) at Buy with Decreased Target to $116 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Jones Maintained (ESAB) at Hold with Increased Target to $131 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Yatin Suneja Reiterated (VIGL) at Buy on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Jones Maintained (ZWS) at Hold with Increased Target to $39 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Jeremy Tonet Maintained (DTM) at Neutral with Increased Target to $115 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Grant Joslin Initiated (INDI) at Neutral and Held Target at $4.5 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Andres Coello Maintained (ASTS) at Sector with Decreased Target to $40 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Mark Zhang Initiated (DOCN) at Buy and Held Target at $45 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Li Watsek Reiterated (ALXO) at Overweight on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Thiago Batista Upgraded (XP) to Buy and Decreased Target to $16 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Race Maintained (HBT) at Neutral with Decreased Target to $26 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Jones Maintained (HLIO) at Buy with Decreased Target to $60 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Jones Maintained (XYL) at Buy with Decreased Target to $150 on, Jan 24th, 2025

Nathan Jones Maintained (XYL) at Buy with Decreased Target to $150 on, Jan 24th, 2025


Published on 2025-01-27 14:07:51 - WOPRAI
  Print publication without navigation


Nathan Jones of Stifel, Maintained "Xylem Inc." (XYL) at Buy with Decreased Target from $166 to $150 on, Jan 24th, 2025.

Nathan has made no other calls on XYL in the last 4 months.



There are 4 other peers that have a rating on XYL. Out of the 4 peers that are also analyzing XYL, 1 agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Joseph Giordano of "TD Cowen" Maintained at Hold with Decreased Target to $125 on, Wednesday, November 6th, 2024


These are the ratings of the 3 analyists that currently disagree with Nathan

  • Andrew Kaplowitz of "Citigroup" Maintained at Buy with Decreased Target to $147 on, Monday, January 13th, 2025
  • Michael Halloran of "Baird" Maintained at Outperform with Decreased Target to $154 on, Friday, November 1st, 2024
  • Deane Dray of "RBC Capital" Maintained at Outperform with Decreased Target to $162 on, Friday, November 1st, 2024
Contributing Sources